Value Sense
LH

Laboratory Corporation of America Holdings (LH)

Last Price$254.01.2%
Market Cap$21.2B

LH Rating

LH Quality rating
6.1
How this score works?
LH Quality rating performance

LH Intrinsic Value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 LH Relative Value is $620.5, which is undervalued by 144.2%, compared to current share price of $254.0.
DCF Value vs Current Share Price
As of Mar 03, 2025 LH DCF Value is N/A, which is undervalued by N/A, compared to current share price of $254.0.
Methodology
Price per share, $
LH
Intrinsic value$621.0
Undervalued by144.4%
Current share price
254.0
Relative value
620.5
DCF value
not available

LH Share Price History

1W 1.0%
1M 2.5%
6M 10.9%
YTD 10.7%
1Y 17.1%
3Y 13.2%
5Y 69.1%
10Y 147.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!

LH Stock Metrics

Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields

LH Stock Financials

LH Income Statement Metrics

Annual
Quarterly
LTM

Revenue

$12.2B -18.3% YoY

Operating Income

$0.7B -59.1% YoY

Net Income

$0.4B -67.3% YoY

LH Cash Flow Statement Metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

$1,327.7M -32.1% YoY

Capital Expenditure (CAPEX)

($453.6M) -2.8% YoY

Free Cash Flow (FCF)

$874.1M -41.7% YoY

LH Income Statement Overview

Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Revenue
$12.2B (18.3%) YoY
Gross profit
$3,364.9M (23.3%) YoY
27.7% margin
Cost of revenue
$8,796.7M (16.2%) YoY
Operating income
$725.6M (59.1%) YoY
6.0% margin
Other: $42.9M
Net interest: $199.6M
Operating expenses
$2,639.3M 17.0% YoY
Pre-tax income
$568.9M (64.1%) YoY
4.7% margin
Net income
$418.0M (67.3%) YoY
3.4% margin
Income tax
$188.5M
33.1% tax rate
R&D
$2,000.0K 0.0% YoY
0.0% of revenue
SG&A
$2,021.4M 1.2% YoY
16.6% of revenue

LH Balance Sheet Overview

Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$16.7B
Current assets ($3,765.4M, 22.5% of total)
Cash & ST investments
$536.8M (3.2%)
Accounts receivables
$2,098.7M (12.5%)
Other current assets
$1,129.9M (6.8%)
Non-current assets ($13.0B, 77.5% of total)
Intangible assets
$3,342.0M (20.0%)
Other non-current assets
$6,679.0M (39.9%)
Financial position
Net Debt
$5,417.4M
$536.8M$5,954.2M
Cash & Short-term Investments
Total Debt
Quick ratio
0.8x
Net Debt to Free Cash Flow
6.2x
Debt to Equity ratio
75.5%

LH Stock Ratios

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Revenue growth
EPS growth
Gross margin
Free Cash Flow margin
Net Debt to FCF
FCF to Interest
ROIC
Shareholder yield

LH Earnings Surprises

Crunching data... Almost there!

LH Dividends

LH Dividend Yield

Crunching data... Almost there!

LH Dividend Per Share

3Y
10Y
30Y
Annual
Quarterly
LTM
1Y Growth
(1.0%)
3Y CAGR
N/A
5Y CAGR
N/A
10Y CAGR
N/A

Competing with LH

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Quality rating
Intrinsic value
1Y Return
Revenue
Free Cash Flow
Revenue growth
FCF margin
Gross margin
ROIC
Total Debt to Equity
LH
$21.2B
6.1
$621.0
144.4% undervalued
17.1%
$13.0B
$1,095.9M
0.8%
8.4%
26.9%
6.0%
24.1%
TMO
$201.0B
6.5
$602.4
15.0% undervalued
(9.7%)
$42.9B
$7,267.0M
0.1%
16.9%
41.5%
8.3%
63.1%
DHR
$151.3B
6.1
$167.0
18.8% overvalued
(19.4%)
$23.9B
$5,296.0M
(0.1%)
22.2%
59.5%
5.9%
32.3%
A
$36.5B
7.4
$103.7
17.9% overvalued
(11.0%)
$6,533.0M
$1,409.0M
(3.0%)
21.6%
65.9%
14.7%
55.8%
IDXX
$36.1B
7.2
$219.3
49.8% overvalued
(23.5%)
$3,897.5M
$798.1M
6.5%
20.5%
61.1%
49.4%
6.3%
IQV
$33.7B
6.1
$301.3
63.0% undervalued
(26.5%)
$15.4B
$2,114.0M
2.5%
13.7%
31.4%
8.8%
21.7%
MTD
$27.1B
7.0
$869.6
31.5% overvalued
(1.4%)
$3,872.4M
$864.4M
2.2%
22.3%
59.1%
49.8%
(1,587.1%)
WAT
$22.2B
6.5
$236.1
36.5% overvalued
7.2%
$2,958.4M
$619.6M
0.1%
20.9%
58.2%
19.4%
0.0%
DGX
$19.6B
6.0
$369.8
109.0% undervalued
44.2%
$9,872.0M
$909.0M
6.7%
9.2%
32.4%
8.8%
102.2%
NTRA
$18.5B
6.0
$70.9
50.4% overvalued
58.6%
$1,532.0M
($33.2M)
54.9%
(2.2%)
57.7%
(44.9%)
54.2%
ILMN
$13.9B
6.2
$147.2
74.8% undervalued
(37.1%)
$4,372.0M
$696.0M
(2.9%)
15.9%
65.4%
34.6%
93.8%

FAQ

What is Laboratory Corporation of America Holdings (LH) stock rating?

As of today, Laboratory Corporation of America Holdings has a stock rating of N/A (out of 10), which is considered Great.

is Laboratory Corporation of America Holdings (LH) a good stock to buy?

As of today, Laboratory Corporation of America Holdings has a Great stock rating, which is N/A undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.